We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WFRD:NASDAQWeatherford International plc Analysis

Data as of 2026-05-28 - not real-time

$106.16

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Weatherford International is trading above its mid‑term and long‑term moving averages but just below the short‑term average, indicating a price that is still respecting recent bullish momentum while facing near‑term pressure. The MACD histogram is negative and the signal line is bearish, suggesting a short‑term downside bias, while the RSI hovers around the neutral zone, offering no clear overbought or oversold signal. Volume has been trending lower, which can exacerbate price volatility that is already elevated for the sector. The stock’s beta is above one, reflecting higher sensitivity to market swings, and the 30‑day volatility is notably high, underscoring a risk‑on environment. On the valuation side, the trailing P/E sits comfortably below the industry average, pointing to relative cheapness, yet the discounted cash‑flow fair value is well beneath the current market price, implying limited upside from a pure DCF perspective. Analysts project a modest upside to the median price target, and the forward P/E suggests earnings improvement ahead. Recent contract awards with a major oil services firm and the release of a comprehensive sustainability report provide fresh positive catalysts. The dividend yield is modest but the payout ratio is low, indicating that the dividend is financially sustainable. Overall, the fundamentals show solid cash generation, a respectable return on equity, and manageable debt levels, while the technicals hint at short‑term caution. Investors should weigh the near‑term bearish technical signals against the longer‑term fundamental strengths and modest upside potential.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD divergence
  • Decreasing volume trend
  • Price approaching short‑term resistance

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Analyst price targets imply upside
  • P/E below industry average
  • New contract wins and sustainability progress

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Sustainable dividend with low payout ratio
  • Strong free cash flow generation
  • Diversified service portfolio reducing cyclical exposure

Key Metrics & Analysis

Financial Health

Revenue Growth-3.40%
Profit Margin9.49%
P/E Ratio16.6
ROE30.78%
ROA8.74%
Debt/Equity92.67
P/B Ratio4.3
Op. Cash Flow$670.0M
Free Cash Flow$447.8M
Industry P/E20.7

Technical Analysis

TrendBullish
RSI49.2
Support$101.35
Resistance$113.15
MA 20$108.02
MA 50$101.87
MA 200$83.56
MACDBearish
VolumeDecreasing
Fear & Greed Index92.34

Valuation

Fair Value$73.21
Target Price$119.92
Upside/Downside12.96%
GradeFair
TypeValue
Dividend Yield1.04%

Risk Assessment

Beta1.13
Volatility35.99%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.